Patents by Inventor Clifford S. Morrison

Clifford S. Morrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Using Electrochemical Bioreactor Module with Recovery of Cofactor
    Publication number: 20210171995
    Abstract: Provided herein are composition and process for using an electrochemical device for the reduction of the oxidized state of phosphorylated or non-phosphorylated nicotinamide adenine dinucleotide to the reduced state in which unwanted products of the electrochemical reduction are recovered as the oxidized state of the phosphorylated or non-phosphorylated nicotinamide adenine dinucleotide and returned to the electrochemical device for reduction.
    Type: Application
    Filed: February 22, 2021
    Publication date: June 10, 2021
    Inventors: Clifford S. Morrison, William B. Armiger, David R. Dodds, Mattheos Koffas
  • Method for using electrochemical bioreactor module with recovery of cofactor
    Patent number: 10927395
    Abstract: Provided herein a re composition and process for using an electrochemical device for the reduction of the oxidized state of phosphorylated or non-phosphorylated nicotinamide adenine dinucleotide to the reduced state in which unwanted products of the electrochemical reduction are recovered as the oxidized state of the phosphorylated or non-phosphorylated nicotinamide adenine dinucleotide and returned to the electrochemical device for reduction.
    Type: Grant
    Filed: March 14, 2017
    Date of Patent: February 23, 2021
    Assignee: Biocheminsights, Inc.
    Inventors: Clifford S. Morrison, William B. Armiger, David R. Dodds, Mattheos Koffas
  • Improved Method for Using Electrochemical Bioreactor Module with Recovery of Cofactor
    Publication number: 20190078127
    Abstract: Provided herein a re composition and process for using an electrochemica 1 device for the reduction of the oxidized state of phosphorylated or non-phosphorylated nicotinamide adenine dinucleotide to the reduced state in which unwanted products of the electrochemical reduction are recovered as the oxidized state of the phosphorylated or non-phosphorylated nicotinamide adenine dinucleotide and returned to the electrochemical device for reduction.
    Type: Application
    Filed: March 14, 2017
    Publication date: March 14, 2019
    Inventors: Clifford S. Morrison, William B. Armiger, David R. Dodds, Mattheos Koffas
  • SYNTHESIS AND USE OF PRODRUG COMPLEXES OF COBALT IN POLYMER THERAPEUTICS
    Publication number: 20150299238
    Abstract: Degradable compounds that can be controlled to degrade and can be used for delivery of a cargo component. Cobalt (III) complexes have been exploited as vehicles for molecular complexes. This disclosure describes the use of such complexes as bioconjugation reagents in crosslinking proteins to form particles, PEGylation of proteins, and the synthesis of (bio)polymer-drug conjugates. The Co-based linkages can be designed to respond to internal stimuli, such as changes in pH and reduction potential, or external stimuli, such as applied electromagnetic radiation. Therapeutics are entrapped within these crosslinked particles, covalently attached to the polymer making up the matrix through additional stimuli-responsive linkages, or could comprise the matrix itself.
    Type: Application
    Filed: April 21, 2015
    Publication date: October 22, 2015
    Inventors: Robby A. Petros, Duong T. Nguyen, Ronaldo J. Cavazos, Clifford S. Morrison, Jana B. Lampe, Alesha N. Harris